Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Momoko Kubo; Taro Kishi; Shinji Matsunaga; Nakao Iwata

doi:10.3233/JAD-150393

Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Momoko Kubo, Taro Kishi, Shinji Matsunaga, Nakao Iwata

Research output: Contribution to journal › Review article › peer-review

28 Citations (Scopus)

Abstract

Background: No comprehensive meta-analysis has been performed concerning the efficacy and tolerability of histamine H3 receptor antagonists (H3R-ANTs) in Alzheimer's disease patients. Objective: We performed a systematic review and meta-analysis of double-blind randomized placebo-controlled trials (RCTs) of H3R-ANTs for Alzheimer's disease.

Original language	English
Pages (from-to)	667-671
Number of pages	5
Journal	Journal of Alzheimer's Disease
Volume	48
Issue number	3
DOIs	https://doi.org/10.3233/JAD-150393
Publication status	Published - 01-10-2015
Externally published	Yes

All Science Journal Classification (ASJC) codes

Geriatrics and Gerontology
Psychiatry and Mental health
Clinical Psychology
General Neuroscience

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3233/JAD-150393

Cite this

@article{25bbd392a5f64cc0a50911b0f0e2341b,

title = "Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials",

abstract = "Background: No comprehensive meta-analysis has been performed concerning the efficacy and tolerability of histamine H3 receptor antagonists (H3R-ANTs) in Alzheimer's disease patients. Objective: We performed a systematic review and meta-analysis of double-blind randomized placebo-controlled trials (RCTs) of H3R-ANTs for Alzheimer's disease.",

author = "Momoko Kubo and Taro Kishi and Shinji Matsunaga and Nakao Iwata",

year = "2015",

month = oct,

day = "1",

doi = "10.3233/JAD-150393",

language = "English",

volume = "48",

pages = "667--671",

journal = "Journal of Alzheimer's Disease",

issn = "1387-2877",

publisher = "SAGE Publications Ltd",

number = "3",

}

TY - JOUR

T1 - Histamine H3 Receptor Antagonists for Alzheimer's Disease

T2 - A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

AU - Kubo, Momoko

AU - Kishi, Taro

AU - Matsunaga, Shinji

AU - Iwata, Nakao

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background: No comprehensive meta-analysis has been performed concerning the efficacy and tolerability of histamine H3 receptor antagonists (H3R-ANTs) in Alzheimer's disease patients. Objective: We performed a systematic review and meta-analysis of double-blind randomized placebo-controlled trials (RCTs) of H3R-ANTs for Alzheimer's disease.

AB - Background: No comprehensive meta-analysis has been performed concerning the efficacy and tolerability of histamine H3 receptor antagonists (H3R-ANTs) in Alzheimer's disease patients. Objective: We performed a systematic review and meta-analysis of double-blind randomized placebo-controlled trials (RCTs) of H3R-ANTs for Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=84943802641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943802641&partnerID=8YFLogxK

U2 - 10.3233/JAD-150393

DO - 10.3233/JAD-150393

M3 - Review article

C2 - 26402104

AN - SCOPUS:84943802641

SN - 1387-2877

VL - 48

SP - 667

EP - 671

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

IS - 3

ER -

Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this